Clinical Trial Update: Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort [Phase 1]

View source ↗

Summary

The update announces the completion of a Phase 1 trial of PTX-100 in patients with advanced malignancies, including a PTCL expansion cohort.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• PTX-100 (PTX-100)

Snippet

Sponsor: Prescient Therapeutics, Ltd. | Conditions: Advanced Cancer, PTCL | Phase 1 | Status: COMPLETED